Finerenone Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with finerenone
L
- L-Arginine (arginine)
- labetalol
- Lamprene (clofazimine)
- Laniroif (aspirin / butalbital / caffeine)
- lanreotide
- lapatinib
- larotrectinib
- Lasix (furosemide)
- Leader Heartburn Relief (cimetidine)
- lefamulin
- lenacapavir
- lesinurad
- Letairis (ambrisentan)
- letermovir
- letrozole / ribociclib
- levamlodipine
- Levatol (penbutolol)
- Levitra (vardenafil)
- levoketoconazole
- Levsin with Phenobarbital (hyoscyamine / phenobarbital)
- Lexiva (fosamprenavir)
- Lexxel (enalapril / felodipine)
- lidocaine / oxytetracycline
- lidocaine / potassium chloride
- Liqrev (sildenafil)
- lisinopril
- Litfulo (ritlecitinib)
- Lo-Aqua (furosemide)
- Lo-Zumandimine (drospirenone / ethinyl estradiol)
- LoCort (dexamethasone)
- lofexidine
- lomitapide
- lonafarnib
- lonapegsomatropin
- Loniten (minoxidil)
- lopinavir / ritonavir
- Lopressor (metoprolol)
- Lopressor HCT (hydrochlorothiazide / metoprolol)
- Loqua (hydrochlorothiazide)
- Lorbrena (lorlatinib)
- lorlatinib
- Loryna (drospirenone / ethinyl estradiol)
- losartan
- Lotensin (benazepril)
- Lotensin HCT (benazepril / hydrochlorothiazide)
- Lotrel (amlodipine / benazepril)
- Lovenox (enoxaparin)
- Lovenox HP (enoxaparin)
- Lozol (indapamide)
- Lucemyra (lofexidine)
- Lufyllin-EPG (dyphylline / ephedrine / guaifenesin / phenobarbital)
- Lugol's (iodine / potassium iodide)
- Lumakras (sotorasib)
- Luminal (phenobarbital)
- Lupkynis (voclosporin)
- Luvox (fluvoxamine)
- Luvox CR (fluvoxamine)
- lvp solution with potassium
- LymePak (doxycycline)
- Lysodren (mitotane)
More about finerenone
- finerenone consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: aldosterone receptor antagonists
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.